Genetics

This blog post examines a recent integrative genetic study investigating whether metabolic alterations contribute causally to the severity of multiple sclerosis. By combining metabolome-wide Mendelian randomization, multivariable analyses, genetic colocalization, cis-Mendelian randomization, and brain cell-type-specific expression data, the researchers identified polyunsaturated fatty acid metabolism as a central biological pathway. The findings particularly implicate reduced FADS1 activity—and, to a lesser extent, disruption of CYP4F2—in greater MS severity, while also highlighting relevant amino acid and mitochondrial metabolic signals. The study provides a mechanistic framework for understanding metabolic heterogeneity in MS, although its preprint status and methodological limitations require cautious interpretation.